Universal Vision Biotechnology Co., Ltd.

NT$126.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:3218Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 24.08%
Div yield 6.13%
ROE 31.24%
Medical Care Facilities
Beta (5Y) 0.37
PE TTM 9.400
TSR TTM (6.30%)
Mkt cap NT$10.72B
ROIC 31.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$141
11.55%
(29.36%)
Hold 12|8|8|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.91
2.02
2.09
2.09
28.73%
36.16%
25.95%
22.38%
RevenueNT$M
846.7
862.0
912.8
942.2
16.44%
12.83%
14.15%
14.44%
Peers (US$323.7M)
Cap (US$)
PE
262.0M
18.33x
Capital
TTM
5Y
10Y
Leveragex
1.988
0.046
0.037
EBIT/Intx
2.673
0.250
0.240
Own earn%
(287.15)
(211.13)
(212.58)
Sh yield%
19.60
30.02
30.37
Owners
Insiders/Inst%
9.82
33.80
Short interest%
2.24
SBC / revenue%
4.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
27–35
$1 testx
0.1
Incr. ROIC%
16